The Apheresis Market covers medical procedures, equipment, systems, and disposable products used to separate specific components from blood while returning the remaining components to the patient or donor. Apheresis can be used for both therapeutic treatment and blood-component collection and has applications across hematology, oncology, nephrology, neurology, immunology, and transfusion medicine.
The market includes therapeutic apheresis, donor apheresis, plasma apheresis, and cell apheresis. Therapeutic procedures can help remove or reduce unwanted substances from the bloodstream, while donor apheresis is used to collect specific blood components such as plasma, platelets, or red blood cells.
According to Market Research Future, the global Apheresis Market was valued at approximately USD 1.2 billion in 2024 and is projected to reach about USD 3.1 billion by 2035, expanding at a CAGR of approximately 9.0% during 2025–2035. Technological improvements, increasing demand for blood components, growing chronic disease prevalence, and wider adoption of automated systems are among the factors supporting market development.
Get Free Sample PDF Brochure:
Apheresis Market Sample Request: https://www.marketresearchfuture.com/sample_request/1508
Market Drivers
Increasing Demand for Blood Components
The growing need for plasma, platelets, and other blood components is supporting the adoption of apheresis technologies. Apheresis collection allows healthcare and blood-collection organizations to obtain selected blood components efficiently, helping address demand associated with transfusion medicine and plasma-derived therapies.
Rising Prevalence of Chronic Diseases
The increasing burden of chronic and complex diseases is creating greater demand for specialized blood-processing procedures. Apheresis can be incorporated into treatment approaches for selected autoimmune, neurological, renal, hematological, and other conditions, creating opportunities for therapeutic applications.
Technological Advancements
Continuous improvements in apheresis machines, blood-separation technologies, automation, monitoring systems, and disposable kits are improving the efficiency and reliability of procedures. Automated systems can provide greater consistency while incorporating safety features and monitoring capabilities.
Growing Demand for Plasma Derivatives
Plasma-derived products such as immunoglobulins and clotting factors are important for the management of several medical conditions. Increasing demand for these products can encourage greater plasma collection activity and consequently support the donor apheresis segment.
Expansion of Therapeutic Applications
Apheresis is being used across an expanding range of therapeutic applications. Its role in autoimmune disorders, neurological conditions, cancer-related treatments, renal disorders, and other specialized medical procedures is helping broaden the addressable market.
Rising Awareness and Healthcare Investment
Greater awareness among healthcare professionals regarding the clinical applications of apheresis, combined with investments in healthcare infrastructure and blood-processing facilities, is creating favorable conditions for market expansion.
Market Challenges
High Cost of Apheresis Equipment
Advanced apheresis machines and related systems can require substantial capital investment. The cost of equipment, disposable kits, maintenance, training, and supporting infrastructure can make adoption challenging for smaller healthcare facilities and organizations operating with limited budgets.
Need for Skilled Healthcare Professionals
Apheresis procedures require trained healthcare professionals who understand blood-processing technologies, patient monitoring, and procedure-specific protocols. A shortage of appropriately trained specialists in certain regions can limit the adoption of advanced systems.
Risk of Procedure-Related Complications
Although apheresis is an established medical procedure, patients may experience complications such as changes in blood pressure, electrolyte imbalance, allergic reactions, bleeding, or other procedure-related effects. Proper patient selection, monitoring, and trained personnel are important for safe treatment.
Regulatory Requirements
Apheresis equipment and disposable products are subject to medical-device and healthcare regulations that differ across countries. Manufacturers must comply with approval, safety, quality, and reporting requirements, which can increase development and commercialization costs.
Limited Access in Developing Regions
The availability of sophisticated apheresis equipment and specialized treatment centers is uneven across regions. Limited healthcare infrastructure, equipment costs, and inadequate access to trained professionals can restrict market penetration in some developing economies.
Browse In-depth Market Research Report on Apheresis Market:
Apheresis Market Research Report: https://www.marketresearchfuture.com/reports/apheresis-market-1508
Market Segmentation
By Product Type:
Therapeutic Apheresis: Therapeutic apheresis is used to remove selected substances or blood components from a patient’s circulation as part of treatment for specific medical conditions. This segment represents a major portion of the market due to its applications across several disease areas.
Donor Apheresis: Donor apheresis enables the collection of specific blood components from healthy donors. It is increasingly important for obtaining plasma, platelets, and other components required for transfusion and pharmaceutical applications.
Plasma Apheresis: Plasma apheresis focuses on collecting plasma while returning other blood components to the donor or patient. Increasing demand for plasma-derived therapies supports opportunities within this segment.
Cell Apheresis: Cell apheresis involves the collection or removal of specific cellular components from blood. It has applications in specialized therapeutic procedures and cellular medicine.
By Application:
Renal Disorders: Apheresis can be used in selected renal-related conditions and treatment protocols, particularly when the removal of specific circulating substances is clinically appropriate.
Neurological Disorders: Therapeutic plasma exchange and related procedures can have applications in certain neurological and neuromuscular disorders, supporting demand for apheresis services.
Cancer Treatment: Apheresis technologies can support selected oncology-related applications and blood-component management. The growing prevalence of cancer also contributes to the broader need for advanced blood-processing technologies.
Autoimmune Disorders: Autoimmune conditions represent an important application area because therapeutic apheresis can be used in selected cases to remove pathogenic antibodies or other circulating factors.
By End User:
Hospitals: Hospitals represent a major end-user segment because they require apheresis systems for therapeutic procedures, transfusion services, and complex patient care.
Blood Donation Centers: Blood donation centers use apheresis technologies to collect specific blood components such as plasma and platelets efficiently from donors.
Research Laboratories: Research laboratories use apheresis technologies and blood components for scientific research, clinical studies, biotechnology applications, and development of new therapeutic approaches.
By Procedure Type:
Manual Apheresis: Manual approaches involve greater operator participation and can remain relevant in facilities where automated equipment is less accessible. They may provide flexibility in certain healthcare environments.
Automated Apheresis: Automated apheresis systems dominate the market because they can improve procedure consistency, collection efficiency, workflow, and monitoring. Technological improvements continue to strengthen demand for automated platforms.
Regional Insights
North America
North America represents a leading regional market for apheresis technologies, supported by advanced healthcare infrastructure, established blood-collection networks, high adoption of medical technologies, and strong research activity. The United States is particularly important because of its extensive healthcare system and demand for therapeutic and donor apheresis procedures.
Europe
Europe is an important market supported by established transfusion medicine systems, technological development, healthcare investments, and increasing demand for blood components. Countries including Germany, France, Italy, and the UK contribute significantly to regional market activity.
Asia-Pacific
Asia-Pacific is expected to experience strong growth as healthcare expenditure increases and access to advanced medical technologies improves. Japan, China, India, and other countries are expanding healthcare capabilities while increasing awareness of blood donation and specialized therapeutic procedures.
The region’s large population, rising incidence of chronic diseases, expanding healthcare infrastructure, and increasing investment in medical technology create significant opportunities for apheresis equipment manufacturers and service providers.
Middle East & Africa
The Middle East and Africa represent developing opportunities for the apheresis industry. Improvements in healthcare infrastructure, increased awareness of blood donation, and growing investment in specialized medical services can support market development. However, equipment costs and limited access to specialized professionals remain important challenges.
Latin America
Latin American countries are gradually expanding their blood-processing and healthcare capabilities. Growing healthcare expenditure, increasing awareness of advanced treatment approaches, and the need for improved blood-component availability can support the adoption of apheresis technologies.
Key Players
The global Apheresis Market includes established medical technology and blood-management companies such as:
- Terumo
- Fresenius Kabi
- Haemonetics
- Grifols
- Octapharma
- Cellerant Therapeutics
- Kedrion
- Blood Centers of America
- Asahi Kasei
These companies compete through product development, technology improvements, geographic expansion, strategic collaborations, and investments in blood-processing solutions.
Industry Trends
Shift Toward Automated Systems
The market is increasingly moving toward automated apheresis platforms that can improve workflow efficiency, procedure consistency, and collection performance. Automation is particularly valuable for high-volume blood centers and healthcare institutions.
Increasing Use of Advanced Blood Separation Technologies
Innovations in centrifugation, membrane filtration, monitoring systems, and disposable components are helping improve the performance of apheresis procedures. These developments can support wider clinical and donor applications.
Growing Importance of Plasma Collection
The increasing need for plasma-derived medicines is strengthening interest in efficient plasma collection. This trend is creating opportunities for donor apheresis systems and specialized plasma-collection infrastructure.
Focus on Patient Safety
Manufacturers are increasingly emphasizing safety features, real-time monitoring, improved disposables, and user-friendly system designs. These improvements can help healthcare professionals perform procedures more efficiently while maintaining patient safety.
Expansion of Therapeutic Applications
Ongoing clinical research is broadening the understanding of how apheresis can be used in different disease areas. This may create new opportunities for therapeutic apheresis in autoimmune, neurological, hematological, renal, and oncology-related applications.
Future Outlook
The Apheresis Market is expected to maintain a strong growth trajectory as healthcare providers increasingly adopt advanced blood-separation and collection technologies. Market Research Future projects the market to increase from approximately USD 1.31 billion in 2025 to around USD 3.1 billion by 2035, representing a CAGR of about 9.0%.
The increasing demand for blood components and plasma-derived products is likely to remain a major opportunity for market participants. Blood donation centers are expected to continue adopting efficient apheresis platforms to improve the collection of plasma and platelets.
Technological innovation will also remain central to market development. Automated systems, improved monitoring, advanced separation technologies, connected devices, and more efficient disposable products can improve operational performance and support wider adoption.
Therapeutic applications are another important growth area. As research expands and clinicians gain greater familiarity with apheresis-based treatment approaches, opportunities may increase across autoimmune, neurological, renal, hematological, and oncology-related applications.
Emerging economies, particularly across Asia-Pacific and other developing healthcare markets, may provide substantial long-term opportunities as healthcare infrastructure improves and access to specialized medical procedures expands.
Overall, rising demand for blood components, increasing chronic disease prevalence, technological innovation, growing plasma requirements, and expanding therapeutic applications are expected to support the continued development of the global Apheresis Market.
Related Reports:
Discover emerging opportunities with in-depth research reports:
Germanium68 Gallium68 Generator Market Size
Germanium68 Gallium68 Generator Market Share
Germanium68 Gallium68 Generator Market Trends
Germanium68 Gallium68 Generator Market Growth
Germanium68 Gallium68 Generator Market Demand
About Market Research Future:
Market Research Future (MRFR) is a global market research company that provides market intelligence and industry analysis across healthcare, medical technology, pharmaceuticals, biotechnology, and other sectors. Its research covers market trends, growth opportunities, competitive landscapes, technologies, applications, end users, and regional developments.
The company’s research reports are designed to help organizations evaluate industry dynamics, identify emerging opportunities, understand competitive environments, and support strategic business decisions.
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
